KUALA LUMPUR, Feb 25 (Bernama) — Public-listed healthcare company, Malaysian Genomics Resource Centre Berhad (MGRC), and its subsidiary, pathology services company Clinipath (Malaysia) Sdn Bhd (Clinipath) today announced the availability of Dtect Colon+, the latest genetic screening test that examines key genes associated with colorectal cancer.
Colorectal cancer (CRC) is one of the most common cancers affecting both adult men and women in Malaysia. As this disease develops to later stages, common symptoms may include altered bowel habits (41.7%), blood in stools (35.5%), abdominal pain (31.5%), weight loss (31.0%), anaemia (9.8%) and intestinal obstruction (9.3%). Unfortunately, the early stage of CRC is often not symptomatic which makes it a difficult disease to detect early.